• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 28 Aug

    MetaVia to Present at Upcoming Investor and Industry Conferences

    CAMBRIDGE, Mass., Aug. 26, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced its participation in upcoming investor and industry conferences. September 3-5: Wells Fargo Healthcare Conference. Hyung Heon Kim, President and Chief Executive Officer will attend this conference in Boston, Massachusetts. September… Read More..

    Share this:
  • 26 Aug

    Catheter Precision Receives Notification of New Patent Issuance for VIVO Product Line

    Revenue Increased 128% Year Over Year and 48% Sequentially FORT MILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced its results of operations for the three… Read More..

    Share this:
  • 26 Aug

    NextNRG’s Patented RenCast™ Platform Tackles the Solar Energy Challenges Highlighted by President Trump

    AI-powered technology addresses cost, efficiency, and reliability barriers, paving the way for scalable solar adoption worldwide MIAMI, Aug. 26, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced the upcoming launch of RenCast™, a patented… Read More..

    Share this:
1 2 3 … 252 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact